Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

23 June 2014

Genocea Announces Positive Top-Line Phase 1 Results for Novel Universal Pneumococcus Vaccine Candidate GEN-004.More

9 January 2014

F-star achieves milestone in collaboration with Boehringer Ingelheim.More

23 December 2013

Genocea Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering.More

9 December 2013

Covagen Secures CHF 42 Million in Series B Financing.More

6 December 2013

Covagen and Tanabe Research Laboratories Expand Strategic Research Collaboration for Development of Bispecific FynomAbs.More

5 December 2013

Genocea Biosciences Initiates Phase 1 Study of Vaccine Candidate Gen-004 to Prevent Infections Caused by Pneumococcus.More


Featured Portfolio